Peter Kopač

Medicine · Health Sciences

21h-index1.8kcitations91works1.82yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Food Allergy and Anaphylaxis Research(32), Asthma and respiratory diseases(22), Allergic Rhinitis and Sensitization(20), Drug-Induced Adverse Reactions(14), Contact Dermatitis and Allergies(11)

Publications89 total

Serum Mas-related G protein-coupled receptor X2 concentration in drug-induced immediate hypersensitivity reactions
Polskie Archiwum Medycyny Wewnętrznej·2026Open Access
Epidemiologija in diagnostika perioperativnih alergijskih reakcij v Sloveniji
Medicinski razgledi·2025
LAMAs in Real-Life Asthma Management—The 2023 EU-LAMA Survey Results
Journal of Respiration·2025Open Access
Dynamics of specific IgE and clinical response to dupilumab in severe asthma
2025
Variability in time to response in severe asthma biologics: a SHARP survey
2025
Hereditary α-tryptasemia in severe asthma is linked to impaired lung function, lower type 2 biomarkers, and poor omalizumab response
2025
Disease Severity, Not Specific Comorbidities Predicts Fatigue in Severe Asthma (SHARP)
2025
Mapping the Severe Asthma Questionnaire to EQ-5D-5L health utility scores in the SHARP CRC registry
2025
Heterogeneity of Aspergillus fumigatus sensitization testing captured by national severe asthma registries in SHARP
2025
Physicians know which patients with asthma benefit most from single inhaler triple therapy (SITT): EU-LAMA survey
2025
Overreliance on oral corticosteroids (OCS) in European asthma management: EU-LAMA survey.
2025
Evidence of efficacy of biologics in smokers with severe asthma in the SHARP CRC registry
2025
GINA step 4 and 5 single inhaler triple therapy (SITT) management in European asthma patients: EU-LAMA survey.
2025
Physicians adjust single inhaler triple therapy (SITT) asthma treatment according to individual patient's conditions: EU LAMA survey
2025
Clinical characteristics of Aspergillus fumigatus sensitised severe asthma patients in severe asthma registry (SHARP)
2025
Online recorded patient reported outcome measures in the Severe Heterogeneous Asthma Research Collaboration Patient-centered (SHARP) registry could provide information for early assessment of response to biologics in patients with severe asthma
2025
Response rate of repeated patient-reported outcome measures for patients with severe asthma in the SHARP CRC registry
2025
The prevalence of genetic variants of the Mas-related G-protein-coupled receptor X2 in patients does not explain perioperative hypersensitivity reactions to neuromuscular blocking agents
Frontiers in Pharmacology·2025· 1 citedOpen Access
Challenges Pertaining to the Optimization of Therapy and the Management of Asthma—Results from the 2023 EU-LAMA Survey
Biomedicines·2025· 1 citedOpen Access
Cytokine Profiles of Bronchoalveolar Lavage in Patients with Interstitial Lung Diseases and Non-Allergic Asthma
International Journal of Molecular Sciences·2025Open Access
page 1 of 5Next →

Frequent Co-authors

Peter Korošec(25), Mitja Košnik(18), Mihaela Zidarn(18), Renato Eržen(12), Nissera Bajrović(12), Ana Koren(12), Matija Rijavec(11), Julij Šelb(9), Pascale Dewachter(7), José Julio Laguna(7), Didier G. Ebo(6), Paul‐Michel Mertès(6), Tomaz Garcez(6), Susanna Voltolini(6), Peter Cooke(6), Vito Sabato(6), Gerald W. Volcheck(6), Mira Šilar(6), Nika Lalek(6), Sabina Škrgat(6)